YTHDF3 inhibitors belong to a specialized chemical class designed to selectively modulate the activity of YTHDF3, a member of the YTH domain-containing family of proteins. YTHDF3 is an RNA-binding protein that is involved in the regulation of mRNA metabolism, particularly in the context of post-transcriptional modifications. The YTHDF family, consisting of YTHDF1, YTHDF2, and YTHDF3, plays a crucial role in mediating the effects of N6-methyladenosine (m6A) modifications on mRNA. YTHDF3, in particular, is known for its interactions with m6A-modified transcripts, influencing processes such as mRNA decay and translation initiation.
Inhibitors targeting YTHDF3 aim to interfere with its RNA-binding capacity, potentially disrupting its role in recognizing and modulating m6A-modified mRNA. By selectively modulating the function of YTHDF3, inhibitors in this chemical class provide researchers with a valuable tool to dissect the complex regulatory networks governed by m6A modifications and RNA-binding proteins. The study of YTHDF3 inhibitors contributes to a deeper understanding of the molecular mechanisms underlying mRNA metabolism and post-transcriptional regulation, offering insights into the dynamic control of gene expression. Additionally, exploring the effects of YTHDF3 inhibitors may have implications for various cellular processes influenced by mRNA modifications, providing a foundation for advancing our knowledge in the field of RNA biology.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Meclofenamic Acid | 644-62-2 | sc-211780 | 5 mg | $402.00 | ||
Meclofenamic acid is a non-selective inhibitor of the FTO demethylase, which is involved in the removal of m^6A modifications. By inhibiting FTO, this compound can potentially increase the amount of m^6A available for recognition by YTHDF3. | ||||||
Rhein | 478-43-3 | sc-205837 sc-205837A | 100 mg 500 mg | $267.00 $333.00 | 2 | |
Rhein is another FTO inhibitor that can indirectly affect YTHDF3 by increasing the levels of m^6A-modified mRNA. | ||||||